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Abstract
Introduction: Fiber-optic bronchoscopy (FOB) is commonly performed in the first line in diagnostic process of haemoptysis. 
However, lots of evidences suggest that in haemoptysis FOB do not always provide additional, useful information to radiological 
diagnostics. Therefore, this study aimed to evaluate the validity of performing FOB as a method of choice in first line diagnostics 
of haemoptysis. 
Material and methods: Data comprised consecutively collected results from patients referred for FOB assessment for clinical 
purposes were retrospectively analysed. We included all examinations, which were performed due to haemoptysis as the only 
indication, excluding any other lung-related conditions. 
Results: 114 patients were finally included to the study. The median age was 59 (IQR: 46–64.75). Active bleeding was visualized 
during examination of 13 (11.4%) patients. Patients with active bleeding did not differ significantly according to age: 59 (54–69) 
vs 59 (45–64) years; W = 532.5, p-value = 0.27, and gender: c2 = 1.68, p-value = 0.2. On the other hand, in 29 (25.44%) 
patients, FOB revealed no visible abnormalities. This subgroup of patients was significantly younger — 46 (34–62) years vs 60 
(53–67) years; W = 782, p-value = 0.003. 
Conclusion: Low number of visualized active bleeding sites suggest overuse of bronchoscopy in diagnosis of haemoptysis. Indi-
cations for this examination should be reconsidered especially in young patients with non-massive haemoptysis.
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Introduction
Haemoptysis is defined as the expectoration 
of blood originating from the tracheobronchial 
tree or pulmonary parenchyma [1]. It can be divid-
ed into non-massive and massive. Massive hae-
moptysis is a life-threatening condition because 
it may cause sudden airway or haemodynamic 
compromise [2]. The most common causes of hae-
moptysis in industrialised nations are bronchitis, 
bronchiectasis and bronchogenic carcinoma [3]. 
Once the airway protection and volume re-
suscitation are ensured, fiberoptic bronchoscopy 
(FOB) plays a pivotal role with regard to localisa-
tion of the anatomic site of bleeding, isolation of 
the involved airway, control of haemorrhage and 
treatment of the underlying cause of haemoptysis 
in case of visible endoluminal lesions [4]. How-
ever, there is no consensus about the timing of 
its performance [5].
Strong evidence suggests that in haemoptysis, 
FOB does not always add additional, useful infor-
mation to radiological diagnostics. Nielsen et al. [6] 
reported that combining FOB and computed to-
mography (CT) does not result in a significant 
increase in sensitivity in discovering malignant or 
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nosed lung-related disease were excluded (e.g. 
neoplasm, asthma, sarcoidosis). Any lesions 
significantly associated with haemoptysis found 
on chest radiogram were the exclusion criterion 
as well. We also excluded patients admitted to 
the department because of overdosing of anti-
coagulants or antiplatelet drugs, as well as with 
any other conditions evidently associated with 
increased probability of respiratory bleeding.
Continuous data were presented as the median 
with interquartile range (IQR). The U-Mann Whit-
ney test was used, when data presented distribu-
tion other than normal. Categorical variables were 
expressed as an absolute value and percentage, and 
were compared using the Chi-square test. P-value 
< 0.05 was considered as statistically significant. 
Data were analysed using R software for 
MacOS (R Core Team (2016). R: A language and 
environment for statistical computing. R Founda-
tion for Statistical Computing, Vienna, Austria). 
Results
A total of 114 patients were finally included 
in the study — 63 (55.26%) males and 51 (44.74%) 
females, with the median age of 59 (46–64.75). 
Figure 1 presents the flow chart of patient selec-
tion for inclusion in the study. 
In 29 (25.44%) people, FOB revealed no visible 
abnormalities. Active bleeding, regardless its cause, 
was found during examination of 13 (11.4%) pa-
tients (Fig. 2). The subjects with active bleeding did 
not differ significantly in terms of age: 59 (54–69) 
years vs 59 (45–64) years; W = 532.5, p-value = 0.27, 
and gender: c2 = 1.68, p-value = 0.2. 
 Figure 1. The flow chart of patient selection for inclusion in the study
non-malignant causes of haemoptysis [6]. Besides 
the obvious benefits associated with the visualis-
ation of active bleeding and opportunity for treat-
ment, the high number of performed FOBs may re-
sult in higher occurrence of potential complications 
such as hypoxaemia, haemodynamic variations, 
fever, infections, bronchospasm, pneumothorax, 
or other severe complications including death [7].
Therefore, the aim of the study was to eval-
uate the validity of performing FOB as a method 
of choice in first line diagnostics of haemoptysis. 
We hypothesise that the use of bronchoscopy in 
this context is often overused.
Material and methods
 The study is observational, retrospective, 
single-site, based on patients admitted to the 
Bronchoscopy Unit of the Department of Pneumol-
ogy and Allergy and Department of General and 
Oncological Pulmonology of Medical University 
of Lodz, suffered from haemoptysis. Only white 
Caucasians were included in the study. The stud-
ies were performed between November 2006 and 
April 2017 by respiratory physicians experienced 
in performing FOB. The results of performed 
examinations were routinely collected in digital 
database of the Bronchoscopy Unit. Conventional 
white light FOB was used in all patients.
Data comprising consecutively collected 
results from patients referred for FOB assess-
ment for clinical purposes were retrospectively 
analysed. We included all examinations that 
were performed due to haemoptysis as the only 
indication. Patients with any previously diag-
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 7115 examinations 
in the database
451 patients 
initially included 
114 patients finally 
included to the study
6664 examinations meet exclusion 
criteria: 
• Indications other than hemoptysis 
• Any lung-related disease as the 
co-indication 
• Duplicated records 
• Incomplete data 
337 patients excluded: 
• Any lung-related disease 
diagnosed prior to examination 
• Any other conditions evidently 
associated with increased 
probability of respiratory bleeding 
• Evidence for overdosing of anti-
coagulants or antiplatelet drugs 
• Incomplete data preclusive 
verification of exclusion criteria 
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We also detected that patients with no visible 
abnormalities were significantly younger — 46 
(34–62) years vs 60 (53–67) years; W = 782, p-value 
= 0.003, however, we found no difference in re-
spect of gender c2 = 1.71, p-value = 0.19.
In the rest of examinations, we observed 
lesions without active bleeding (63.16%). In this 
group, FOB revealed: features characteristic for 
chronic bronchitis (61 patients; 84.72%), in-
trabronchial tumor (4 patients; 5.56%), or other 
unspecified lesions (7 patients; 9.72%) (Fig. 2).
Our database revealed 4 patients with mas-
sive haemoptysis, what precluded further analy-
ses of that subgroup. 
Discussion
Our results showed a low number of visual-
ised active bleeding (11.4%). Also, we did not 
detect any significant difference between patients 
in terms of age and gender, when stratified by the 
visualisation of active bleeding. 
In other diagnosed conditions such as bron-
chitis, neoplasms, or suspicion of diffused al-
veolar haemorrhage, the examination provided 
no additional, clinically useful information to 
radiological diagnostics. Moreover, often it had 
no impact on further proceedings. 
Furthermore, in more than a quarter of pa-
tients, FOB did not reveal any pathological chang-
es. We also observed that FOBs, in which we 
observed no visible lesions, were performed in 
significantly younger patients.
Presented results might arise from restric-
tions of FOB following the character, anatom-
ical location and size of lesions. It has limited 
sensitivity in diagnosing distant bronchial and 
parenchymal abnormalities. However, it is noted 
that FOB is better in evaluating mucosal abnor-
malities and providing material for pathological 
diagnosis [8].
In patients presenting haemoptysis, besides 
FOB, chest radiography and CT for primary 
screening are used. Many studies were per-
formed to compare value of these examinations 
[8–13]. Davoodi et al. [9] compared diagnostic 
accuracy of multi-detector CT (MDCT) and FOB 
in haemoptysis, and reported that MDCT scan 
detected the site of bleeding more efficiently and 
had higher sensitivity in identifying the cause 
of haemoptysis. Likewise, Thirumaran et al. [8] 
concluded that even though CT and FOB are 
complementary, CT is preferable in detecting ab-
normalities that explain the cause of haemoptysis. 
Moreover, in non-massive haemoptysis, Gasparini 
recommended to perform bronchoscopy after CT 
scan [5]. According to previous studies, in many 
causes of haemoptysis, e.g. bronchiectasis, idi-
opathic pulmonary fibrosis (IPF) and neoplasm, 
FOB is inferior in identification of pathological 
lesions in comparison to CT [8, 9, 14]. In the 
context of bronchogenic carcinoma, Sharma et al. 
[13]  concluded that in patients with normal chest 
radiogram and haemoptysis, FOB plays a minor 
role in the condition, especially when risk factors 
are absent. Moreover, there is an evidence that if 
chest CT does not find any pathological changes, 
FOB is most unlikely to reveal anything of signif-
icance [12]. 
According to previous investigations and 
our results, and taking into account the balance 
between the risk and benefits of the procedure, 
the role of FOB in the first line diagnostic pro-
cess of haemoptysis ought to be reconsidered. 
Essentially, focused medical history and physi-
cal examination should help identify aetiologic 
clues [11], and subsequent procedures should 
be considered as additional tools for differential 
diagnosis. 
There are several limitations of the study, 
that need to be considered. First of all, as a retro-
spective, single-institution study, it is burdened 
by all limitations associated with this type of data 
collection, including an absence of data regarding 
potential confounding factors. Moreover, we were 
not able to verify severity of haemoptysis, because 
in available digital records there is a lack of data 
about estimated amount of expectorated blood. 
This is why, we did not perform analysis taking 
into account the severity of bleeding. Moreover, 
our database comprises 4 patients with massive 
haemoptysis, what precluded further reliable 
analysis of that subgroup. Finally, due to retro-
spective type of analysis, we were not able to pro-
 Figure 2. Endoscopic results of bronchoscopy
No visible 
abnormalities
Active bleeding 
25.44%
11.4%63.16%
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active bleeding
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vide complete imaging data to verify our results 
with the type and distribution of CT-detected 
abnormalities. To provide this information, we 
need a sufficiently powered prospective study on 
a well-described sample.
Conclusion
A low number of visualised active bleed-
ing sites suggests overuse of bronchoscopy in 
diagnosis of haemoptysis. Indications for this 
examination should be reconsidered especially 
in young patients with non-massive haemoptysis.
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